Sign in: Staff/Students
Liverpool has been awarded £5M to improve personalised health using a range of new technoogies
The Chancellor of the Exchequer, George Osborne, has announced that a partnership led by the Medical Research Council (MRC) will invest over £230 million in a range of revolutionary technologies aimed at identifying the causes of diseases such as cancer and dementia.
The University of Liverpool will lead on one of 23 key projects supported by the Clinical Research Infrastructure Initiative, focused on investigating how differences in the cellular and molecular make-up of people affect how they respond to diseases and treatment.
The UK has played a major role in pioneering the use of these technologies in the last 30-40 years and is home to many of the leading experts in the field.
The funding, which brings together support from UK Government, devolved administrations, Arthritis Research UK, British Heart Foundation, the Wellcome Trust and Cancer Research UK, will focus on the most sophisticated imaging technologies in the world to further develop their capabilities by using UK expertise.
Led by Professor Munir Pirmohamed, Director of the University’s MRC Centre for Drug Safety Science, the £5 million Liverpool project was successful in the ‘Technologies for Stratified Medicines’ strand of the funding scheme.
Professor Pirmohamed said: “With this funding we will look at patient samples using the latest and most sensitive technologies available in different ‘experimental’ systems. These range from cutting edge imaging techniques, to experiments on single cells.
“By combining these data with careful clinical observations of patients, we will ultimately be able to tailor treatments for individual patients so that they are not only effective but also safe.”
For more information about the different projects, please see http://www.mrc.ac.uk/research/initiatives/clinical-research-capabilities-and-technologies-initiative/
You must be logged in to post a comment.
All recent news
Lateral flow tests detect most people at risk of transmitting Covid-19
Free digital skills training for Liverpool students
Social disadvantage in the UK has a lasting impact on childhood asthma
Win a year’s tuition fees with Santander Universities UK
How to share your feedback with us – Student Feedback Hub
Professor Eithne Costello from @LivUni on the link between Type 2 Diabetes and Pancreatic Cancer #ITVTonight at 8pm.
Professor Chris Holloran of The University Of Liverpool (@LivUni) explains the importance of diagnosing Pancreatic Cancer early.
You can watch the full episode on #ITVTonight at 8pm
Researchers from @LivCancerRes feature in a new @ITVTonight film about #PancreaticCancer.
Profs Chris Halloran & Eithne Costello discuss the importance of early detection & the research taking place to help to improve outcomes.
📺 Watch 'Britain's Hidden Killer' on ITV at 8pm.